| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |